GeneDx Holdings (WGSWW) Cash from Investing Activities (2020 - 2026)

GeneDx Holdings (WGSWW) has 7 years of Cash from Investing Activities data on file, last reported at -$17.3 million in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$17.3 million, down 83.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$69.4 million (down 71.77% YoY), and the FY2025 annual result was -$61.5 million, down 104.16% from the prior year.
• Cash from Investing Activities declined to -$17.3 million in Q1 2026 per WGSWW's latest filing, from -$11.1 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $843000.0 in Q1 2024 and troughed at -$130.3 million in Q2 2022.
• A 5-year average of -$17.3 million and a median of -$7.8 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities sank 2807.77% in 2022, then jumped 282.47% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$2.8 million in 2022, then plunged by 71.39% to -$4.9 million in 2023, then surged by 89.33% to -$519000.0 in 2024, then tumbled by 2033.33% to -$11.1 million in 2025, then plunged by 55.84% to -$17.3 million in 2026.
• Business Quant data shows WGSWW's Cash from Investing Activities at -$17.3 million in Q1 2026, -$11.1 million in Q4 2025, and -$4.7 million in Q3 2025.